AirSculpt Technologies, Inc. Common Stock 2026 Q2 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- AirSculpt Technologies reported second quarter fiscal 2026 revenue of $42.9 million, a 2.5% decrease versus the prior year quarter on a reported basis but stable on a comparable same center basis with 1% case growth.
- Gross margin expanded to roughly 61% of revenue, with cost of services at $16.6 million.
- Selling, general and administrative expenses increased by approximately $750,000 to $23.4 million, reflecting a $1.5 million increase in marketing and brand development investment.
- Customer acquisition cost was approximately $3,500 per case, up from $2,900 in the prior year quarter due to intentional marketing investments.
- Adjusted EBITDA was $4.9 million or 11.5% of revenue, down $900,000 from the prior year.
- Cash provided by operating activities after capital expenditures was approximately $3.8 million through June 30, 2026, slightly up year over year.
- The company ended the quarter with roughly $19 million in cash, $5 million available on its revolver, and $44 million in gross debt, remaining in compliance with all covenants.
- AirSculpt raised approximately $5 million through its ATM program during the quarter and $20 million year to date, while paying down $13 million of debt.
- The company has expanded its procedure offerings, including over 200 skin excision procedures and new services such as upper blepharoplasty and Mastopexy, and announced a partnership with Tiger Aesthetics to offer Allo, a structural adipose tissue allograft for non-surgical body contouring, starting later this quarter.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first five paragraphs, organized by speaker.
Greetings, and welcome to the AirSculpt Technologies, Inc. second quarter 2026 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone requires operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Allison Malkin with ICR.
Please begin. Good morning, everyone.
Thank you for joining us to discuss AirSculpt Technologies results for the second quarter of fiscal 2026. Joining me on the call today are Yogi Jashnani, Chief Executive Officer, and Michael Arthur, Chief Financial Officer. For this morning's call, Yogi will begin with a review of our second quarter results and the progress made on our strategic priorities. Michael will share a detailed review of our second quarter and first six-month performance and guidance. Before we begin, I would like to remind you that this conference call may include forward-looking statements. These statements may include our future expectations regarding financial results and guidance, market opportunities, and our growth.
Risks and uncertainties that may impact these statements and could cause actual future results to differ materially from currently projected results are described in this morning's press release and the reports we will file with the SEC, all of which can be found on our website at investors.airsculpt.com. We undertake no obligation to revise or update any forward-looking statements or information except as required by law. During our call today, we will also reference their non-GAAP financial measures. We use non-GAAP measures in some of our financial discussions as we believe they more accurately represent the true operational performance and underlying results of our business. A reconciliation of these measures can be found in our earnings release as filed this morning and in our most recent 10-K, which will also be available on our website. With that, I'll turn the call over to Yogi.
Thank you, Allison, and good morning, everyone. Welcome to AirSculpt's second quarter earnings call. I am pleased to share that our second quarter and first half results marked meaningful progress on our transformation. For the quarter, on a comparable basis, we delivered stable revenue and positive same-center case growth. Same-center sales began the quarter positively and saw moderating sales trends in June, which we attribute to a dynamic consumer environment. Overall, we generated a 21 percentage point improvement in same-center sales versus Q2 last year and a 23 percentage point improvement year to date. Over the past 18 months, we have broadened our consumer reach to capture the growing opportunity presented by GLP-1 patients, bolstered our talent, invested in new marketing strategies, and strengthened our balance sheet to provide the financial flexibility to support future growth.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
9 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring